Fairvalue-Calculator Fairvalue-Calculator
EN DE

Abingdon Health Plc (ABDX) Fair Value & Analysis

Healthcare · GB · Market cap 31.4M GBX

Pricep0.1125
Fair Valuep0.0900
Upside-20.0%
Quality95/100
Evidence: Low Range p0.0700 – p0.1200

Fair value as of: Jun 24, 2026

Analysis

Abingdon Health Plc (ABDX) currently trades at p0.1125, while our model-based Fair Value estimate is p0.0900 — implying the stock looks roughly 20.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -96% Danaher Corporation (DHR) -52% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -66% Lonza Group (LZAGY) -59% Agilent Technologies, Inc (A) -54%

Frequently asked questions

Is Abingdon Health Plc (ABDX) undervalued?
As of Jun 24, 2026, our model estimates a fair value of p0.0900 versus a price of p0.1125 — about −20% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ABDX?
Our 21-model fair value for Abingdon Health Plc is p0.0900 (as of Jun 24, 2026), built from audited fundamentals. The current price is p0.1125.
What is the quality score of ABDX?
Abingdon Health Plc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.